Hiramatsu, Naoki <br/><br/>
Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.  [electronic resource] 

 -  Journal of gastroenterology  Sep 2011 
 - 1111-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1435-5922 
<br/><br/><label>Standard No.: </label>10.1007/s00535-011-0412-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia, Hemolytic--chemically induced<br/>Antiviral Agents--administration & dosage<br/>Cohort Studies<br/>Decision Trees<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Reproducibility of Results<br/>Retrospective Studies<br/>Ribavirin--administration & dosage<br/>Severity of Illness Index